SHIFT trial showed reduced hospital admission rates and mortality with ivabradine, in patients with refractory sustained sinus tachycardia and heart failure with reduced ejection fraction (HFrEF). We present a case… Click to show full abstract
SHIFT trial showed reduced hospital admission rates and mortality with ivabradine, in patients with refractory sustained sinus tachycardia and heart failure with reduced ejection fraction (HFrEF). We present a case of a patient with normal QTc on maximum beta blocker therapy and aggressive diuretics
               
Click one of the above tabs to view related content.